Alternatives to death: Understanding androgen-independent prostate cancer

被引：0
|
作者：
Joel B. Nelson
机构：
[1] Brady Urological Institute Johns Hopkins Medical Institutions ,
来源：
Nature Medicine | 1998年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Decreased levels of caveolin promote sensitivity to androgen withdrawal in prostate cancer cells, suggesting another therapeutic target for the treatment of prostate cancer (pages 1062–1064).
引用
下载
收藏
页码：1011 / 1012
页数：1
相关论文
共 50 条
  • [21] Signal Transduction Targets in Androgen-independent Prostate Cancer
    Jian Zhou
    Jessica Scholes
    Jer-Tsong Hsieh
    Cancer and Metastasis Reviews, 2001, 20 : 351 - 362
  • [22] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Beer, TM
    Garzotto, M
    Henner, WD
    Eilers, KM
    Wersinger, EM
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 968 - 970
  • [23] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    T M Beer
    M Garzotto
    W D Henner
    K M Eilers
    E M Wersinger
    British Journal of Cancer, 2003, 89 : 968 - 970
  • [24] Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase
    Sumitomo, M
    Asano, T
    Asakuma, J
    Asano, T
    Nanus, DM
    Hayakawa, M
    CLINICAL CANCER RESEARCH, 2004, 10 (01) : 260 - 266
  • [25] Current chemotherapeutic approaches for androgen-independent prostate cancer
    Rumohr, Jon A.
    Chang, Sam S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (06) : 529 - 533
  • [26] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Bellmunt, Joaquim
    Albiol, Santiago
    Albanell, Joan
    BJU INTERNATIONAL, 2007, 100 (03) : 490 - 492
  • [27] Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer
    Borden, Lester S., Jr.
    Clark, Peter E.
    Lovato, James
    Hall, M. Craig
    Stindt, Diana
    Harmon, Michele
    Mohler, Randi M.
    Torti, Frank M.
    CANCER, 2006, 107 (05) : 1093 - 1100
  • [28] Mechanisms underlying the development of androgen-independent prostate cancer
    Pienta, KJ
    Bradley, D
    CLINICAL CANCER RESEARCH, 2006, 12 (06) : 1665 - 1671
  • [29] Pten inactivation and the emergence of androgen-independent prostate cancer
    Shen, Michael M.
    Abate-Shen, Cory
    CANCER RESEARCH, 2007, 67 (14) : 6535 - 6538
  • [30] Is chemotherapy the standard for asymptomatic androgen-independent prostate cancer?
    Nabhan, Chadi
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2413 - 2414
12345